FDA granted regulatory milestones to Medtronic, which is integrating with Abbott's Instinct sensor.
3 reports, 3 independent
Updated Aug 6
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA granted regulatory milestones to Medtronic, which is integrating with Abbott's Instinct sensor.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Medtronic plans to integrate with Abbott’s Libre sensors as both firms develop multi-analyte sensor technology.Sub-event
- The FDA is currently reviewing Medtronic's submission for its MiniMed 780G system, specifically regarding its use for Type 2 diabetes and label expansion into Europe.Sub-event
FDA grants regulatory milestones to Medtronic, enabling integration with Abbott's sensor.1 source
Keep exploring
The entities involved
- FDA
-
Medtronic plc
medical device company
Related events
- Abbott Laboratories and Medtronic plc operate within the healthcare device sector.
- Arise is seeking FDA approval for a drug as of October 7, 2026.
- LabCorp is involved in FDA-approved drugs. Intuitive Surgical's systems were FDA-cleared. Masimo develops noninvasive patient monitoring technologies.
- FDA is willing to review updated submissions, while biotech hubs leverage AI to ease clinical development bottlenecks.
- CMR Surgical, based in Cambridge, U.K., received FDA authorization to scale up its US market presence.
Coverage
Newest first; wire copies grouped- finanznachrichten.de
- PR NewswireFDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE:
- GlobeNewswireOrchestra BioMed Reports Second Quarter 2025 Financial Results and Highlights Recent Business Updates Secured over $111 million in proceeds and committed capital following completion of strategic tra